Patent details

Basic Information

Publication number:

EP4116325

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP221809767

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHODS OF TREATING RHEUMATOID ARTHRITIS USING IL-17 ANTAGONISTS

French Title of Invention:

PROCÉDÉS DE TRAITEMENT DE LA POLYARTHRITE RHUMATOÏDE AU MOYEN D'ANTAGONISTES D'IL-17

German Title of Invention:

VERFAHREN ZUR BEHANDLUNG VON RHEUMATOIDER ARTHRITIS MIT IL-17-ANTAGONISTEN

SPC Number:

Dates

Filing date:

04/11/2011

Grant date:

01/04/2026

EP Publication Date:

11/01/2023

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

01/04/2026

EP B1 Publication Date:

01/04/2026

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

04/11/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

25/03/2026

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

THANGAVELU, Karthinathan

Address:

Switzerland (CH)

2

Name:

MACHACEK, Matthias

Address:

Switzerland (CH)

3

Name:

MPOFU, Shepard

Address:

Switzerland (CH)

4

Name:

RICHARDS, Hanno

Address:

Switzerland (CH)

Priority

Priority Number:

41053310 P

Priority Date:

05/11/2010

Priority Country:

United States (US)

Classification

IPC classification:

C07K 16/24; A61K 39/395; A61P 37/02;

Publication

European Patent Bulletin

Issue number:

202614

Publication date:

01/04/2026

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

30/11/2026

Annual Fee Number:

16

Annual Fee Amount:

230 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages